NCT05025826View on ClinicalTrials.gov

Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

October 31, 2026

Conditions
Metastatic Gastric Cancer
Interventions
OTHER

Phycocare

Phycocare every day during 9 months (except days of chemotherapy: no Phycocare)

OTHER

Placebo

Placebo every day during 9 months (except days of chemotherapy = no Placebo)

Trial Locations (9)

44000

RECRUITING

Hôpital le Confluent, Nantes

49300

RECRUITING

Centre Hospitalier de Cholet, Cholet

Unknown

RECRUITING

Clermont-Ferrand UH, Clermont-Ferrand

WITHDRAWN

DIJON UH, Dijon

RECRUITING

Chd La Roche Sur Yon, La Roche-sur-Yon

RECRUITING

Nantes Uh, Nantes

RECRUITING

Saint Gregoire Clinique, Rennes

RECRUITING

Mutaliste Clinic Saint Nazaire, Saint-Nazaire

RECRUITING

Foch Suresnes Hosptial, Suresnes

All Listed Sponsors
collaborator

Algosource

INDUSTRY

lead

Nantes University Hospital

OTHER